Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
IDEAYA Biosciences
InSilico Medicine Hong Kong Limited
Kezar Life Sciences, Inc.
Incyte Corporation
Nurix Therapeutics, Inc.
Incyte Corporation
Context Therapeutics Inc.
Suzhou Maximum Bio-tech Co., Ltd.
Symphogen A/S
Pfizer
Quadriga Biosciences, Inc.
Eli Lilly and Company
Shionogi Inc.
Incyte Corporation
National Cancer Institute (NCI)
University of Chicago
National Institutes of Health Clinical Center (CC)
Pediatric Brain Tumor Consortium